<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="149709">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01960088</url>
  </required_header>
  <id_info>
    <org_study_id>13-2889</org_study_id>
    <nct_id>NCT01960088</nct_id>
  </id_info>
  <brief_title>Adolescent Vaccination in Pharmacies</brief_title>
  <acronym>AVIP</acronym>
  <official_title>Building Evidence to Expand Adolescent Vaccination in Pharmacies</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of North Carolina, Chapel Hill</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Merck Sharp &amp; Dohme Corp.</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>University of North Carolina, Chapel Hill</source>
  <oversight_info>
    <authority>United States: Institutional Review Board</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study aims to expand the evidence supporting pharmacy provision of adolescent vaccines,
      including human papillomavirus (HPV) vaccine. In the first part of the study, we will
      characterize parents' attitudes and support for pharmacy provision of adolescent vaccines in
      a national survey. In the second part of the study, we will provide HPV vaccines and other
      vaccines (Tdap, meningococcal, varicella, influenza) to 100 adolescents in a local community
      pharmacy in Chapel Hill, North Carolina.  This portion of the study will identify the
      systems and workflow needed to provide vaccines effectively and safely, characterize
      parents' and their adolescents' attitudes toward receiving vaccine services in a pharmacy,
      and characterize pharmacists' attitudes toward providing adolescent vaccine services in a
      pharmacy.
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date>August 2014</start_date>
  <completion_date type="Anticipated">April 2016</completion_date>
  <primary_completion_date type="Anticipated">December 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <study_design>Time Perspective: Cross-Sectional</study_design>
  <primary_outcome>
    <measure>Parents' willingness to get their adolescent children  HPV vaccine in pharmacy</measure>
    <time_frame>At time of study</time_frame>
    <safety_issue>No</safety_issue>
    <description>Outcome is for the national survey of parents.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Parents' satisfaction with HPV vaccine vaccine administration in the pharmacy</measure>
    <time_frame>At time of vaccine administration</time_frame>
    <safety_issue>No</safety_issue>
    <description>Outcome is for demonstration study in a community pharmacy.</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">1300</enrollment>
  <condition>Evaluating Attitudes Toward HPV Vaccinations in Pharmacies</condition>
  <condition>Evaluating the Provision of HPV Vaccines in a Pharmacy</condition>
  <arm_group>
    <arm_group_label>Adolescent (11-18 years old) and their parents</arm_group_label>
    <description>National study: there is no intervention Pharmacy demonstration project: HPV vaccine delivery</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>HPV vaccine</intervention_name>
    <arm_group_label>Adolescent (11-18 years old) and their parents</arm_group_label>
    <other_name>Gardasil</other_name>
  </intervention>
  <biospec_retention>None Retained</biospec_retention>
  <biospec_descr>
    <textblock>
      N=1200 anticipated in national study N=100 anticipated in pharmacy demonstration project
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        National survey: Parents of adolescents ages 11-18. Pharmacy sample: Parents of adolescent
        boys and girls, ages 11-18 whose families reside in the Chapel Hill area, and their
        adolescents.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        NATIONAL SURVEY (probability sample)

        Inclusion Criteria:

          -  Being a member of the GfK Knowledge Panel

          -  Having a child age 11-18.

        Exclusion Criteria:

        ● None

        PHARMACY DEMONSTRATION PROJECT (convenience sample)

        Inclusion Criteria:

          -  Having an adolescent child, ages 11-18 years old, who is healthy, and for whom HPV
             vaccine is indicated

          -  Child is with the parent

        Exclusion Criteria:

        ● Being the parent of an adolescent who is immunocompromised, or has other chronic
        illness, has known anaphylactoid/hypersensitivity reactions to components of HPV vaccine
        used, or is pregnant or plan to be pregnant within a month of vaccination.
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>11 Years</minimum_age>
    <maximum_age>18 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Noel T Brewer, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of North Carolina, Chapel Hill</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Megan E Hall, MPH</last_name>
    <phone>919.843.8962</phone>
    <email>meghall@email.unc.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Parth D Shah, PharmD</last_name>
    <phone>626.757.1504</phone>
    <email>pdshah@live.unc.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>UNC Gillings School of Global Public Health</name>
      <address>
        <city>Chapel Hill</city>
        <state>North Carolina</state>
        <zip>27599</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Megan E Hall, MPH</last_name>
      <phone>919-843-8962</phone>
      <email>meghall@email.unc.edu</email>
    </contact>
    <contact_backup>
      <last_name>Parth D Shah, PharmD</last_name>
      <phone>626.757.1504</phone>
      <email>pdshah@live.unc.edu</email>
    </contact_backup>
    <investigator>
      <last_name>Noel T Brewer, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>May 2014</verification_date>
  <lastchanged_date>May 11, 2014</lastchanged_date>
  <firstreceived_date>October 8, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of North Carolina, Chapel Hill</investigator_affiliation>
    <investigator_full_name>Noel Brewer, PhD</investigator_full_name>
    <investigator_title>Associate Professor</investigator_title>
  </responsible_party>
  <keyword>Adolescent vaccines</keyword>
  <keyword>HPV vaccine</keyword>
  <keyword>Pharmacies</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
